EKF Diagnostics Holdings PLC Reduction of capital (0033Q)
September 06 2017 - 8:42AM
UK Regulatory
TIDMEKF
RNS Number : 0033Q
EKF Diagnostics Holdings PLC
06 September 2017
EKF Diagnostics Holdings plc
("EKF", the "Company")
Reduction of capital
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical
diagnostics business, announces that the reduction of the Company's
share capital necessary in order for the Company to proceed with
its share buyback plan of up to 15% of the Company's current issued
share capital has now been approved by the court.
Details of the reduction of capital were set out in the circular
to shareholders dated 26 June 2017 and the proposal was approved by
shareholders at the General Meeting held on 27 July 2017.
The Company is currently in a close period ahead of the
publication of its interim results on 11 September 2017 and further
announcements will be made in connection with the commencement of
the share buyback at the appropriate time.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Alex Price / Shaun Dobson
/ Ali Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLFMTTMBIMBMR
(END) Dow Jones Newswires
September 06, 2017 08:42 ET (12:42 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024